연구동향 분석

Application of Antimicrobial Peptide LL-37 as an Adjuvant for Middle East Respiratory Syndrome-Coronavirus Antigen Induces an Efficient Protective Immune Response Against Viral Infection After Intranasal Immunization

Kim Ju Yang Ye Lin Jeong Yongsu 장용석 2022년

논문상세정보
인용/피인용
' Application of Antimicrobial Peptide LL-37 as an Adjuvant for Middle East Respiratory Syndrome-Coronavirus Antigen Induces an Efficient Protective Immune Response Against Viral Infection After Intranasal Immunization' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Infection
  • antigen
  • antimicrobial peptide
  • mers-cov
  • vaccine
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
430 0

0.0%

' Application of Antimicrobial Peptide LL-37 as an Adjuvant for Middle East Respiratory Syndrome-Coronavirus Antigen Induces an Efficient Protective Immune Response Against Viral Infection After Intranasal Immunization' 의 참고문헌

  • Vaccination strategies for mucosal immune responses
    Ogra PL [2001]
  • The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies
    Gierer S [2013]
  • The role of defensins in HIV pathogenesis
    Pace BT [2017]
  • The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2 : vaccine design strategies
    Molaei S [2021]
  • The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations
    Agerberth B [2000]
  • The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization
    Davidson DJ [2004]
  • Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenza
  • Spotlight on human LL-37, an immunomodulatory peptide with promising cell-penetrating properties
    Seil M [2010]
  • Significance of LL-37 on immunomodulation and disease outcome
    Yang B [2020]
  • Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
    Betts MR [2003]
  • Seasonal influenza vaccines
    Fiore AE [2009]
  • Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design
    Ma C [2014]
  • Revisiting an old acquaintance : CD26 and its molecular mechanisms in T cell function
    Ohnuma K [2008]
  • Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection
    Barlan A [2014]
  • Recent Insights into Cellular Crosstalk in Respiratory and Gastrointestinal Mucosal Immune Systems
    김새해 [2020]
  • Rapid generation of a mouse model for Middle East respiratory syndrome
    Zhao , J. , [2014]
  • Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19
    이푸름 [2020]
  • Nasal immunization with major epitopecontaining ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model
    Seo KW [2013]
  • NALT-versus Peyer’s-patch-mediated mucosal immunity
    Kiyono H [2004]
  • Mucosal immunity and vaccines
    Holmgren J [2005]
  • Middle East respiratory syndrome coronavirus(MERS-CoV)infection : epidemiology, pathogenesis and clinical characteristics
    Nassar MS [2018]
  • Middle East respiratory syndrome
    Memish ZA [2020]
  • Middle East respiratory syndrome
    Zumla A [2015]
  • Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis
    김주 [2020]
  • LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1(FPRL1)as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells
    De Yang [2000]
  • Intranasal COVID-19 vaccines : from bench to bed
    Alu A [2022]
  • Intestinal antimicrobial peptides during homeostasis, infection, and disease
    Muniz LR [2012]
  • Inside the mucosal immune system
    McGhee JR [2012]
  • Induction of mucosal immunity by pulmonary administration of a cell-targeting nanoparticle
    Kurosaki T [2021]
  • In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2
    Alagarasu K [2017]
  • Immunomodulatory role of the antimicrobial LL-37 peptide in autoimmune diseases and viral infections
    Pahar B [2020]
  • Immune response in humans to a nasal boost with Streptococcus mutans antigens
    Childers NK [2006]
  • IL-10 and IL-22 in mucosal immunity : driving protection and pathology
    Wei HX [2020]
  • Human defensins and LL-37 in mucosal immunity
    Doss M [2010]
  • Human cathelicidin peptide LL-37 modulates the effects of IFN-γ on APCs
    Nijnik A [2009]
  • Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4
  • Global hotspots and correlates of emerging zoonotic diseases
    Allen T [2017]
  • Engineered human cathelicidin antimicrobial peptides inhibit Ebola virus infection
    Yu Y [2020]
  • Emergence of a CD4+CD28-granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection
  • Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells
  • Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
    Raj VS [2013]
  • Depot medroxyprogesterone acetate(DMPA)use is associated with elevated innate immune effector molecules in cervicovaginal secretions of HIV-1-uninfected women
    Guthrie BL [2015]
  • Cutting edge : LL-37-mediated formyl peptide receptor-2 signaling in follicular dendritic cells contributes to B cell activation in Peyer’s patch germinal centers
    Kim SH [2017]
  • Current status of DNA vaccines and their route of administration
    Alpar HO [2002]
  • Conjugation of human β-defensin 2 to spike protein receptor-binding domain induces antigen-specific protective immunity against Middle East respiratory syndromecoronavirus infection in human dipeptidyl peptidase 4 transgenic mice
    Kim J [2020]
  • Cathelicidins have direct antiviral activity against respiratory syncytial virus in vitro and protective function in vivo in mice and humans
    Currie SM [2016]
  • Cathelicidins display conserved direct antiviral activity towards rhinovirus
    Sousa FH [2017]
  • Cathelicidin-derived antimicrobial peptides inhibit zika virus through direct inactivation and interferon pathway
    He M [2018]
  • Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
  • CD8+ T cell effector mechanisms in resistance to infection
    Harty JT [2000]
  • CD4 CTL, a cytotoxic subset of CD4+ T cells, their differentiation and function
    Takeuchi A [2017]
  • Antimicrobial peptide LL-37 promotes antigen-specific immune responses in mice by enhancing Th17-skewed mucosal and systemic immunities
    Kim SH [2015]
  • Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines
    김새해 [2014]
  • Antigen cross-presentation by dendritic cell subsets : one general or all sergeants
    Nierkens S [2013]
  • An overview of spike surface glycoprotein in severe acute respiratory syndrome–coronavirus
  • An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
    Hassan AO [2021]
  • A recombinant receptorbinding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4(hDPP4)transgenic mice from MERS-CoV infection
    Tai W [2016]